Namuscla यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

namuscla

lupin europe gmbh - mexiletine hydrochloride - myotonic kvilla - hjarta meðferð - namuscla er ætlað fyrir einkennum meðferð vöðvaherping í fullorðinn sjúklinga með ekki-dystrophic myotonic kvilla.

BroPair Spiromax यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

bropair spiromax

teva b.v. - salmeterol xinafoate, flútikasón nef - astma - lyf til veikindi öndunarvegi sjúkdómum, - bropair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seffalair Spiromax यूरोपीय संघ - आइसलैंडी - EMA (European Medicines Agency)

seffalair spiromax

teva b.v. - fluticasone propionate, salmeterol xinafoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - seffalair spiromax is indicated in the regular treatment of asthma in adults and adolescents aged 12 years and older not adequately controlled with inhaled corticosteroids and ‘as needed’ inhaled short-acting β₂ agonists.

Seretide Innúðalyf, dreifa 25/250 míkróg/skammt आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

seretide innúðalyf, dreifa 25/250 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innúðalyf, dreifa - 25/250 míkróg/skammt

Seretide Innúðalyf, dreifa 25/125 míkróg/skammt आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

seretide innúðalyf, dreifa 25/125 míkróg/skammt

glaxosmithkline pharma a/s - salmeterolum xínafóat; fluticasonum própíónat - innúðalyf, dreifa - 25/125 míkróg/skammt

Salmex Innöndunarduft, afmældir skammtar 50 míkróg/500 míkróg/skammt आइसलैंड - आइसलैंडी - LYFJASTOFNUN (Icelandic Medicines Agency)

salmex innöndunarduft, afmældir skammtar 50 míkróg/500 míkróg/skammt

glenmark pharmaceuticals nordic ab* - salmeterolum xínafóat; fluticasonum própíónat - innöndunarduft, afmældir skammtar - 50 míkróg/500 míkróg/skammt